Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...
Extended-release buprenorphine was an effective treatment for pregnant women with opioid use disorder (OUD) and safe for their babies, according to an open-label randomized trial.
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...
In a clinical trial, a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder (OUD) during pregnancy led to higher rates of ...
12d
Spokane's Deaconess Hospital starts program to combat drug withdrawal with long-lasting medication
A pilot program from MultiCare Deaconess Hospital now provides long lasting opioid withdrawal medication. The injectable buprenorphine will provide a much more stable basis for patients to ...
Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...
News Medical on MSN
State bans on prior authorization show limited impact on buprenorphine treatment retention
State laws that ban insurance prior authorization for buprenorphine-a leading medication for opioid use disorder-may not help more patients stay in treatment for the recommended minimum of 180 days, ...
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Prevention Point Philadelphia’s drop-in center on Kensington Avenue used to be a ...
A novel use of a common treatment for opioid addiction might not be as effective as first believed, according to a recently published study authored by doctors at UCSF and the San Francisco Department ...
Officials in Hennepin and Ramsey County are using buprenorphine, a medication to treat opiate withdrawals symptoms that affect a growing number of Minnesotans. More cities are taking notice. As a ...
OUD, which is the third most prevalent substance use disorder worldwide, affected an estimated 3.7% of US adults (9,367,000) in 2022 and caused 53,774 deaths in the US in 2024. Medications for opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results